Enterprise Value
39.93M
Cash
229.4M
Avg Qtr Burn
-15.19M
Short % of Float
17.11%
Insider Ownership
2.32%
Institutional Own.
-
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PC14586 (p53 reactivator) Details Solid tumor/s, Cancer | Phase 1/2 Data readout | |
PC14586 (p53 reactivator) + KEYTRUDA Details Solid tumor/s, Cancer | Phase 1/2 Update |